Cerevance
Looking. Seeing.
Cambridge, United Kingdom · Founded 2016 · $209.5M raised
- Headquarters
- Cambridge
- Employees
- 51–200
- Founded
- 2016
- Business Model
- B2B
- Website
- cerevance.com
- Total Funding
- $209.5M
- Last Round
- $20.0M Series CMay 2026
- Rounds
- 7
Totals include recorded grants and other qualifying funding, not just equity. What counts toward funding.
Indexed holds 7 funding rounds and 7 investors for this company. The full record is or through the API.
About
Cerevance develops cell-type specific treatments for CNS disorders including Parkinson's, Alzheimer's, and ALS. Using over 26,000 human brain tissue samples and its proprietary NETSseq platform, the company identifies novel drug targets with advanced machine learning to move beyond traditional dopamine-based therapies.
Summary
Cerevance is a Biotech company based in Cambridge, United Kingdom, founded in 2016. It has raised $209.5M in total across 7 rounds, most recently a $20.0M Series C round in May 2026. Investors include GV, Bill Gates and Foresite Capital.
Tech & App Stack
3 technologies & apps tracked
Every product and vendor across these categories, with where each signal came from.
Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.
Funding History
May 2026
Sign up to see all 7 events
Funding: Series A through Series C. Amounts, valuations, and investors where available.
Investors
Similar Companies
China's leading blood products manufacturer
One of the world's largest contract research organizations (CROs), providing end-to-end clinical ...
Global contract research organization providing comprehensive drug development and laboratory ser...
Specialty pharmaceutical company
Appears in
Your company? Embed this profile
Add the live badge to your site — it stays current as your funding data updates.
<a href="https://indexed.vc/companies/cerevance"><img src="https://indexed.vc/api/badge/company/cerevance" alt="Cerevance on Indexed.vc" width="260" height="76" /></a>